Categories
Solara Active Pharma Sciences Limited — Board Meeting, 15-05-2026: Outcome of Board Meeting
15-05-2026 · 01:16 pm
Solara Active Pharma Sciences announced its board approved Q4 consolidated results with a ₹9.60 Cr profit and FY26 consolidated loss of ₹7.41 Cr. The company issued a final call for ₹134.99 Cr from its rights issue and is exploring a CRAMS & Polymers business demerger.
No comments yet. Be the first to comment!
All announcements from Solara Active Pharma Sciences Limited